A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

PHASE2CompletedINTERVENTIONAL
Enrollment

511

Participants

Timeline

Start Date

October 12, 2017

Primary Completion Date

May 24, 2019

Study Completion Date

May 24, 2019

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

Multivalent

Pneumococcal conjugate vaccine

BIOLOGICAL

Tdap

Tetanus, diphtheria, acellular pertussis vaccine

BIOLOGICAL

polysaccharide

23-valent pneumococcal polysaccharide vaccine

Trial Locations (18)

28209

PMG Research of Charlotte, LLC, Charlotte

28401

PMG Research of Wilmington, LLC, Wilmington

29445

Medical Research South, LLC, Goose Creek

31406

Meridian Clinical Research, LLC, Savannah

35216

Achieve Clinical Research LLC, Birmingham

40004

Kentucky Pediatric/Adult Research, Bardstown

67010

Augusta Family Practice, Augusta

Heartland Research Associates, LLC, Augusta

67114

Axtell Clinic, P.A., Newton

Heartland Research Associates, LLC, Newton

67205

Heartland Research Associates, LLC, Wichita

68134

Meridian Clinical Research LLC, Omaha

68701

Meridian Clinical Research, LLC, Norfolk

84088

Advanced Clinical Research, West Jordan

84109

J. Lewis Research Incorporated, Foothill Family Clinic, Salt Lake City

84121

J. Lewis Research, Incorporated/Foothill Family Clinic South, Salt Lake City

90703

Core Healthcare Group, Cerritos

02886

Omega Medical Research, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY